Lumbar bone mineral density in very long-term renal transplant recipients: Impact of circulating sex hormones

Osteoporosis International

Volumn 16, Issue 12, 2005, Pages 1611-1620

  Brandenburg, Vincent M ^a   Ketteler, Markus ^a   Heussen, Nicole ^a   Politt, Dirk ^a   Frank, Rolf D ^a   Westenfeld, Ralf ^a   Ittel, Thomas H ^a   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Bone loss; Bone mineral density; Post transplantation bone disease; Renal transplantation; Sex hormones

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; PREDNISOLONE; PROGESTERONE; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; GENDER; HUMAN; KIDNEY GRAFT; LONGITUDINAL STUDY; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; POSTOPERATIVE PERIOD; PREMENOPAUSE; PRIORITY JOURNAL; RECIPIENT; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SEX DIFFERENCE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; DEHYDROEPIANDROSTERONE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FRACTURES, MALUNITED; GONADAL STEROID HORMONES; HUMANS; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; LUMBAR VERTEBRAE; LUTEINIZING HORMONE; MALE; MENOPAUSE; MIDDLE AGED; PREDNISOLONE; PROGESTERONE; RETROSPECTIVE STUDIES; SEX FACTORS; TESTOSTERONE; TIME FACTORS;

EID: 29044443214     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-1884-6     Document Type: Article

References (36)

1. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD (1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544-550
2. Grotz W, Mundinger A, Gugel B, Exner V, Reichelt A, Schollmeyer P (1994) Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplant Proc 26:2652-2653
3. Kim H, Chang K, Lee T, Kwon J, Park S (1998) Bone mineral density after renal transplantation. Transplant Proc 30:3029-3030
4. Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT (2003) Long-term fracture risk following renal transplantation: a population-based study. Osteoporos Int:160-167
5. Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM (1999) Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456-463
6. Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ (2003) Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116-1120
7. Grotz WH, Mundinger FA, Rasenack J, Speidel L, Olschewski M, Exner VM, Schollmeyer PJ (1995) Bone loss after kidney transplantation: a longitudinal study in 115 graft recipients. Nephrol Dial Transplant 10:2096-2100
8. Brandenburg VM, Westenfeld R, Ketteler M (2004) The fate of bone after renal transplantation. J Nephrol 17:190-204
9. Mikuls TR, Julian BA, Bartolucci A, Saag KG (2003) Bone mineral density changes within 6 months of renal transplantation. Transplantation 75:49-54
10. Lippuner K, Casez JP, Horber FF, Jaeger P (1998) Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients. J Clin Endocrinol Metab 83:3795-3802
11. Brandenburg VM, Politt D, Ketteler M, Fassbender WJ, Heussen N, Westenfeld R, Freuding T, Floege J, Ittel TH (2004) Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 77:1566-1571
12. Nam JH, Moon JI, Chung SS, Kim SI, Park KI, Song YD, Kim KR, Lee HC, Huh K, Lim SK (2000) Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation. Transplant Proc 32:1876
13. Ugur A, Guvener N, Isiklar I, Karakayali H, Erdal R (2000) Efficiency of preventive treatment for osteoporosis after renal transplantation. Transplant Proc 32:556-557
14. Feber J, Cochat P, Braillon P, Castelo F, Martin X, Glastre C, Chapuis F, David L, Meunier PJ (1994) Bone mineral density after renal transplantation in children. J Pediatr 125:870-875
15. Brandenburg VM, Ketteler M, Fassbender WJ, Heussen N, Freuding T, Floege J, Ittel TH (2002) Development of lumbar bone mineral density in the late course after kidney transplantation. Am J Kidney Dis 40:1066-1074
16. Grotz WH, Rump LC, Niessen A, Schmidt-Gayk H, Reichelt A, Kirste G, Olschewski M, Schollmeyer PJ (1998) Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 66:1004-1008
17. Pichette V, Bonnardeaux A, Prudhomme L, Gagne M, Cardinal J, Ouimet D (1996) Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study. Am J Kidney Dis 28:105-114
18. Cruz DN, Wysolmerski JJ, Brickel HM, Gundberg CG, Simpson CA, Mitnick MA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ (2001) Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study. Transplantation 72:83-88
19. Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B (1998) Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med 339:733-738
20. Roe SD, Porter CJ, Godber IM, Hosking DJ, Cassidy MJ (2005) Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporos Int 16(2):142-148 [epub, 2004]
21. Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, Hosking D, Jaeger P, Kaufman JM, Leite M, Leon J, Liberman U, Menkes CJ, Meunier PJ, Reid I, Rodriguez J, Romanowicz A, Seeman E, Vermeulen A, Hirsch LJ, Lombardi A, Plezia K, Santora AC, Yates AJ, Yuan W (1996) Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone 18:141-150
22. Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488-501
23. Liberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443
24. Montalban C, De Francisco AL, Marinoso ML, Zubimendi JA, Unzueta MG, Amado JA, Arias M (2003) Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int [Suppl] 129-132
25. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292-299
26. Cueto-Manzano AM, Konel S, Hutchison AJ, Crowley V, France MW, Freemont AJ, Adams JE, Mawer B, Gokal R (1999) Bone loss in long-term renal transplantation: histopathology and densitometry analysis. Kidney Int 55:2021-2029
27. Horber FF, Casez JP, Steiger U, Czerniak A, Montandon A, Jaeger P (1994) Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1-9
28. Almond MK, Kwan JT, Evans K, Cunningham J (1994) Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52-57
29. Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak JA, Hricik DE (1994) Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186-1189
30. Patel S, Kwan JT, McCloskey E, McGee G, Thomas G, Johnson D, Wills R, Ogunremi L, Barron J (2001) Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863-1870
31. Cueto-Manzano AM, Freemont AJ, Adams JE, Mawer B, Gokal R, Hutchison AJ (2001) Association of sex hormone status with the bone loss of renal transplant patients. Nephrol Dial Transplant 16:1245-1250
32. Leavey SF, Weitzel WF (2002) Endocrine abnormalities in chronic renal failure. Endocrinol Metab Clin North Am 31:107-119
33. Tauchmanova L, Carrano R, Sabbatini M, De Rosa M, Orio F, Palomba S, Cascella T, Lombardi G, Federico S, Colao A (2004) Hypothalamic-pituitary- gonadal axis function after successful kidney transplantation in men and women. Hum Reprod 19:867-873
34. (2002) European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.8. Bone disease. Nephrol Dial Transplant 17[Suppl 4]:43-48
35. Warren MP (2004) A comparative review of the risks and benefits of hormone replacement therapy regimens. Am J Obstet Gynecol 190:1141-1167
36. Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269-2274